HealthcareJul 18, 2026

Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Company Profile Analysis

Book Demo Subscribe Now

Zhejiang Jiuzhou Pharmaceutical Co., Ltd - Healthcare showcase

Year Founded & Workforce

1997-12-31

5,000 Employees

Industry

Healthcare

Services

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Overview

Company Headquarters: China

Founded: 1998

Workforce: 5,000+

Company Working: Zhejiang Jiuzhou Pharmaceutical Co., Ltd (Jiuzhou Pharma) is into research and development and production of APIs/intermediates. It provides products and Contract Research Organization (CRO)/ Contract Manufacturing Organization (CMO) services to customers. Jiuzhou Pharma is a leading API manufacturer and supplier of Carbamazepine, Oxcarbazepine, Ketoprofen, and Gliclazidein globally. The company was honored with various titles, such as “Top 100 Chinese Pharmaceutical Industry ”, “China's Leading Exporter of APIs ”, “National High-tech Enterprise”, “National Technology Innovation Demonstration Enterprises ”，“Zhejiang ‘sanming’ cultivation pilot enterprises”， and “Zhejiang Innovative leading enterprises ”, among others. It is also awarded to be Zhejiang’s famous export brand. It has an excellent manufacturing and R&D system. It has established five production sites in Taizhou, Zhejiang, and Yancheng, Jiangsu

Strategy

Jiuzhou Pharma focuses on investing in research and development of new pharmaceutical technologies especially in the area of high-end fluorine chemistry, asymmetric chiral synthesis, and glycosides and biological enzyme technology that reflects the high level of technical research and development strength.

Company Snapshot

5,000

Employees

1997-12-31

Founded

China

Headquarters

SWOT Analysis

Strengths

Wide product portfolio
Strong distribution network

Weaknesses

Manufacturing unit is present only in China

Opportunities

Increase presence in contract manufacturing
Expansion with the help of strategic acquisitions

Threats

Increasing competition in the market
Exchange rate fluctuations

Product Offering

Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Duloxetine Intermediate ((S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine (CAS No. 132335-44-5))

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Zhejiang Jiuzhou Pharmaceutical Co., Ltd as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Company Headquarters: China Founded: 1998 Workforce: 5,000+ Company Working: Zhejiang Jiuzhou Pharmaceutical Co., Ltd (Jiuzhou Pharma) is into research and development and production of APIs/intermediates. It provides products and Contract Research Organization (CRO)/ Contract Manufacturing Organization (CMO) services to customers. Jiuzhou Pharma is a leading API manufacturer and supplier of Carbamazepine, Oxcarbazepine, Ketoprofen, and Gliclazidein globally. The company was honored with various titles, such as “Top 100 Chinese Pharmaceutical Industry ”, “China's Leading Exporter of APIs ”, “National High-tech Enterprise”, “National Technology Innovation Demonstration Enterprises ”，“Zhejiang ‘sanming’ cultivation pilot enterprises”， and “Zhejiang Innovative leading enterprises ”, among others. It is also awarded to be Zhejiang’s famous export brand. It has an excellent manufacturing and R&D system. It has established five production sites in Taizhou, Zhejiang, and Yancheng, Jiangsu

Starting from

$4,950